GlassScriptPhysician profile
Brent A Frame
NPI 1407879703
$2,814.31
in general payments reported to CMS, 2019-2025
19 companies · $792 in 2025
The $792 reported for 2025 was more than what 76% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $725 · 2020: $84.09 · 2021: $285 · 2022: $371 · 2023: $369 · 2024: $188 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,349.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $750.69 | 2019-2025 | Ortholoc 2 Lapifuse, Augment Injectable, Phalinx |
| Smith+Nephew, INC. | $531.06 | 2019-2025 | Grafix Pl, Stravix Pl, Panta 2 |
| Treace Medical Concepts, INC. | $408.57 | 2022-2025 | |
| Kerecis Limited | $228.63 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Nevro Corp. | $205.85 | 2021-2024 | Senza |
| Rikco International, LLC | $110.03 | 2019 | |
| Depuy Synthes Sales INC. | $80.96 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $74.60 | 2024-2025 | Nuzyra |
| Grt US Holding, INC. | $74.09 | 2021-2022 | |
| Djo, LLC | $73.69 | 2019 | |
| Orthofix Medical, INC. | $62.83 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $56.69 | 2025 | |
| Accufix Surgical INC. | $36.23 | 2023 | Accu-Joint |
| Bioventus LLC | $32.06 | 2021-2022 | |
| Medtronic, INC. | $21.28 | 2025 | Inceptiv |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $18.08 | 2025 | Stimulan |
| Averitas Pharma INC. | $17.59 | 2023 | Qutenza |
| Convatec INC. | $17.03 | 2022 | |
| Alfasigma USA, INC. | $14.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Frame listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.